Cargando…

Recurrence‐free interval 12 months after local treatment of mast cell tumors in dogs using intratumoral injection of tigilanol tiglate

BACKGROUND: Tigilanol tiglate (TT) is a novel small molecule approved by the European Medicines Agency for intratumoral treatment of mast cell tumors (MCTs) in dogs. In a randomized controlled clinical efficacy and safety study in the United States, 85 of 116 dogs that received a single TT injection...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jones, Pamela D., Campbell, Justine E., Brown, Graham, Johannes, Chad M., Reddell, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2020
Materias:	SMALL ANIMAL
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848364/ https://www.ncbi.nlm.nih.gov/pubmed/33350511 http://dx.doi.org/10.1111/jvim.16018

Ejemplares similares

Wound formation, wound size, and progression of wound healing after intratumoral treatment of mast cell tumors in dogs with tigilanol tiglate
por: Reddell, Paul, et al.
Publicado: (2021)

Randomized controlled clinical study evaluating the efficacy and safety of intratumoral treatment of canine mast cell tumors with tigilanol tiglate (EBC‐46)
por: De Ridder, Thomas R., et al.
Publicado: (2020)

Intratumoural Treatment of 18 Cytologically Diagnosed Canine High-Grade Mast Cell Tumours With Tigilanol Tiglate
por: Brown, Graham K., et al.
Publicado: (2021)

Tigilanol Tiglate-Mediated Margins: A Comparison With Surgical Margins in Successful Treatment of Canine Mast Cell Tumours
por: De Ridder, Thomas, et al.
Publicado: (2021)

Treatment of multiple synchronous canine mast cell tumours using intratumoural tigilanol tiglate
por: Brown, Graham K., et al.
Publicado: (2022)

Dose Characterization of the Investigational Anticancer Drug Tigilanol Tiglate (EBC-46) in the Local Treatment of Canine Mast Cell Tumors
por: Miller, Jane, et al.
Publicado: (2019)

Use of the Intratumoural Anticancer Drug Tigilanol Tiglate in Two Horses
por: De Ridder, Thomas, et al.
Publicado: (2020)

Identification of Gene Biomarkers for Tigilanol Tiglate Content in Fontainea picrosperma
por: Mitu, Shahida A, et al.
Publicado: (2022)

Activation of PKC supports the anticancer activity of tigilanol tiglate and related epoxytiglianes
por: Cullen, Jason K., et al.
Publicado: (2021)

Phase I dose-escalation study to determine the safety, tolerability, preliminary efficacy and pharmacokinetics of an intratumoral injection of tigilanol tiglate (EBC-46)
por: Panizza, Benedict J., et al.
Publicado: (2019)

Progressive cutaneous viral pigmented plaques in three Hungarian Vizslas and the response of lesions to topical tigilanol tiglate gel
por: Hansen, Naomi, et al.
Publicado: (2017)

Outcomes of adjunctive radiation therapy for the treatment of mast cell tumors in dogs and assessment of toxicity: A multicenter observational study of 300 dogs
por: Mason, Sarah L., et al.
Publicado: (2021)

Pulse‐Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs
por: Burton, J.H., et al.
Publicado: (2015)

Desoxycorticosterone Pivalate Duration of Action and Individualized Dosing Intervals in Dogs with Primary Hypoadrenocorticism
por: Jaffey, J.A., et al.
Publicado: (2017)

c‐Kit Mutation and Localization Status as Response Predictors in Mast Cell Tumors in Dogs Treated with Prednisone and Toceranib or Vinblastine
por: Weishaar, K.M., et al.
Publicado: (2017)

Reference intervals for plasma, urinary, and salivary concentrations of free metanephrines in dogs: Relevance to the diagnosis of pheochromocytoma
por: van den Berg, Marit F., et al.
Publicado: (2023)

Echocardiographic reference intervals for volumetric measurements of the left ventricle using the Simpson's method of discs in 1331 dogs
por: Wess, Gerhard, et al.
Publicado: (2021)

Antimicrobials in dog‐to‐dog bite wounds: A retrospective study of 1526 dog bite events (1999‐2019)
por: Kalnins, Nicole J., et al.
Publicado: (2022)

Evaluation of a long‐acting injectable formulation of omeprazole in healthy dogs
por: Odunayo, Adesola, et al.
Publicado: (2022)

Left ventricular M‐mode prediction intervals in 7651 dogs: Population‐wide and selected breed‐specific values
por: Esser, Lilith Carla, et al.
Publicado: (2020)

Echocardiographic reference intervals for right ventricular indices, including 3‐dimensional volume and 2‐dimensional strain measurements in healthy dogs
por: Feldhütter, Elisabeth K., et al.
Publicado: (2021)

Efficacy and Safety of Injectable Robenacoxib for the Treatment of Pain Associated With Soft Tissue Surgery in Dogs
por: Friton, G., et al.
Publicado: (2017)

Effect of Intravenous or Perivascular Injection of Synthetic Adrenocorticotropic Hormone on Stimulation Test Results in Dogs
por: Johnson, C.M., et al.
Publicado: (2017)

Spontaneous Course of Biliary Sludge Over 12 Months in Dogs with Ultrasonographically Identified Biliary Sludge
por: DeMonaco, S.M., et al.
Publicado: (2016)

Echocardiographic quantitation of left heart size and function in 122 healthy dogs: A prospective study proposing reference intervals and assessing repeatability
por: Visser, Lance C., et al.
Publicado: (2019)

Effect of oral or injectable supplementation with cobalamin in dogs with hypocobalaminemia caused by chronic enteropathy or exocrine pancreatic insufficiency
por: Chang, Chee‐Hoon, et al.
Publicado: (2022)

Toxicity, outcome, and management of anthracycline overdoses in 16 dogs
por: Lawson, Haylie C., et al.
Publicado: (2021)

Long‐term survival of dogs treated for gallbladder mucocele by cholecystectomy, medical management, or both
por: Parkanzky, Max, et al.
Publicado: (2019)

Hypophysitis, Panhypopituitarism, and Hypothalamitis in a Scottish Terrier Dog
por: Polledo, L., et al.
Publicado: (2017)

Evaluation of the Live Biotherapeutic Product, Asymptomatic Bacteriuria Escherichia coli 2‐12, in Healthy Dogs and Dogs with Clinical Recurrent UTI
por: Segev, G., et al.
Publicado: (2017)

Effects of desmopressin acetate administration in healthy dogs receiving prednisolone
por: Galati, Pamela, et al.
Publicado: (2021)

Treatment of recurrent hunting‐associated respiratory distress episodes in 2 dogs
por: Dumont, Renaud, et al.
Publicado: (2023)

Mechanical dilation, botulinum toxin A injection, and surgical myotomy with fundoplication for treatment of lower esophageal sphincter achalasia‐like syndrome in dogs
por: Grobman, M. E, et al.
Publicado: (2019)

Plasma amino acid profiles in dogs with closed extrahepatic portosystemic shunts are only partially improved 3 months after successful gradual attenuation
por: Devriendt, Nausikaa, et al.
Publicado: (2021)

Evaluation of the Cortisol‐to‐ACTH Ratio in Dogs with Hypoadrenocorticism, Dogs with Diseases Mimicking Hypoadrenocorticism and in Healthy Dogs
por: Boretti, F.S., et al.
Publicado: (2015)

Targeted sequencing of candidate gene regions for myelofibrosis in dogs
por: Campbell, Amelia G., et al.
Publicado: (2022)

Infrared Thermography in Dogs with Mammary Tumors and Healthy Dogs
por: Pavelski, M., et al.
Publicado: (2015)

Epidemiologic evaluation of calcium oxalate urolithiasis in dogs in the United States: 2010‐2015
por: Hunprasit, Vachira, et al.
Publicado: (2019)

Clinical Risk Factors for Early Seizure Recurrence in Dogs Hospitalized for Seizure Evaluation
por: Kwiatkowska, M., et al.
Publicado: (2018)

Risk factors associated with short‐term mortality and recurrence of status epilepticus in dogs
por: Fentem, Rory, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nj85db2d17qt5jie76a2o1p2io